Table: begin end state 1 19 cytoplasmic 20 42 transmembrane 43 58 non-cytoplasmic 59 79 transmembrane 80 90 cytoplasmic 91 109 transmembrane 110 114 non-cytoplasmic 115 137 transmembrane 138 154 cytoplasmic 155 175 transmembrane 176 182 non-cytoplasmic 183 202 transmembrane 203 258 cytoplasmic 259 282 transmembrane 283 297 non-cytoplasmic 298 319 transmembrane 320 325 cytoplasmic 326 344 transmembrane 345 355 non-cytoplasmic 356 379 transmembrane 380 395 cytoplasmic 396 435 transmembrane 436 438 non-cytoplasmic 439 458 cytoplasmic
Input: >Ga0059261_1777 MHSVSASFAGAPDEEARATVAIILSAAGAALGGLLFGFDTAVISGATQALQLQFGLTDAM LGFTVASALIGTVLGSLIAGAPADRFGRKGVMLTVAIAYVVSSLGTGLAPDLNAFLVFRF MGGLAIGAASVVTPIYIAEVSPARFRGRLVAMNQLNIVLGILIAFLSNYIIAGLVQYDVA WRWMFGIVAVPSTIFLLVTLLLPESPRWLAIHGQADRARDVMQRLGFADPRAELARIELA EAREEAAGKPRLFQRSHFTPVACAIAIAMFNQLSGINALLYYAPRIFELAGAGADSALLQ SIAVGGTNLVFTVAALFLIDRFGRRPLLFVGSVICAATLLLVGWQLESAKPDGTLILFGL LGFIAAFAMSQGAVIWVFISEVFPSAVRGKGQALGSTTHWVMAAAITWAFPVFAASVGGW VFAFFGAMMLLQLLWTWKFMPETNGIALEDMNLGSARA
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server